Stocks and Investing
Stocks and Investing
Fri, February 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Whit Mayo Maintained (AMED) at Hold with Increased Target to $147 on, Feb 18th, 2022
Whit Mayo of SVB Leerink, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $145 to $147 on, Feb 18th, 2022.
Whit has made no other calls on AMED in the last 4 months.
There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 1 agrees with Whit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $185 on, Thursday, November 4th, 2021
These are the ratings of the 5 analyists that currently disagree with Whit
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $213 on, Tuesday, December 21st, 2021
- John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $225 on, Monday, November 8th, 2021
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $205 on, Thursday, November 4th, 2021
- Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $221 on, Thursday, November 4th, 2021
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $225 on, Wednesday, November 3rd, 2021
Contributing Sources